Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clearside Biomedical, Inc.
A randomized, masked, controlled trial to study the safety and efficacy of suprachoroidal CLS-TA in conjunction with intravitreal aflibercept in subjects with retinal vein occlusion
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has a clinical diagnosis of RVO in the study eye
Has a CST of ≥ 300 µm in the study eye
Has an ETDRS BCVA score of ≥ 20 letters read and ≤ 70 letters read in the study eye;
Is naïve to local pharmacologic treatment for RVO in the study eye;
You may not be if
Any active ocular disease or infection in the study eye other than RVO
History of glaucoma, intraocular pressure \> 21 mmHg or ocular hypertension requiring more than one medication
Any uncontrolled systemic disease that, in the opinion of the Investigator, would preclude participation in the study
Any evidence of neovascularization in the study eye
